Insys executive allegedly gave doctor lapdance while promoting opioid drug, Artie Lange enters long-term drug treatment program, OxyContin maker explored “attractive” anti-addiction market.
OxyContin Maker Explored Expansion Into ‘Attractive’ Anti-Addiction Market [ProPublica]
According to a new report, Purdue Pharma expressed interest in joining the “attractive market” of addiction recovery. Pharma executives saw a “natural link” between selling opioids and treating addiction.
Artie Lange Cancels Upcoming Shows, Enters Long-Term Drug Treatment Program [NJ.com]
Comedian Artie Lange is heading to rehab, amid his public battle with his long-term drug abuse. The comedian announced his “long-term” hiatus on social media.
Insys Executive Gave Doctor Lapdance While Promoting Drug, Witness Says [Reuters]
A former drug company executive allegedly gave one “shady” doctor a lapdance. Insys Therapeutics is on trial for allegedly bribing doctors to prescribe its fentanyl spray, Subsys.
Perspective: The Value of a Relapse [PsychCentral]
Are relapses just a part of the journey, or something to be dreaded? Associate Editor Therese Borchard explains why she’s “glad mine happened.”
Drug Company Execs Under Pressure to Testify [The Hill]
Drug companies have been invited to testify before Congress, but most have refused. Lawmakers are investigating Big Pharma’s pricing practices.
BC Ministry to Stem High Rate of Overdose Deaths Among Recent Inmates [CBC]
New “community transition teams” aim to reduce rates of fatal overdoses amongst recently released inmates. A recent report revealed a significant link between the criminal justice system and fatal overdoses.
Fighting the Stigma of Mental Illness Through Music [NY Times]
Me2 Orchestra welcomes musicians with mental illness. It is one example of the healing potential of music.
Minnesota Lawmakers: Tax Drug Makers for Role in Opioid Crisis [KFGO]
State legislators are working to force drug companies to pay for their role in fueling drug addiction. The bipartisan initiative would raise registration fees to offset the cost of the drug crisis.